Synaptic Aspects of the Cellular Prion Protein

Advances in Organ Biology

Volumn 2, Issue C, 1997, Pages 99-111

  Fournier, Jean Guy ^a   Escaig Haye, Françoise ^a   de Villemeur, Thierry Billette ^a   Robain, Olivier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002182423     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60182-2     Document Type: Article

References (57)

1. Askanas V., Bilak M., King Engel W., Leclerc A., and Tomé F. Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions. Neurosc. Lett. 159 (1993) 111-114
2. Askanas V., Bilak M., King Engel W., Alvarez R.B., Tomé F., and Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport. 5 (1993) 25-28
3. Bell J.E., and Ironside J.W. Neuropathology of spongiform encephalopathies in humans. Br. Med. Bull. 49 (1993) 738-777
4. Bendheim P.E., Brown H.R., Rudelli R.D., Scala B.S., Goller A.A., Wen G.Y., Kascsak R.J., Cashman N.R., and Bolton D.C. Nearly ubiquitous tissue distribution of the scrapie agent precusor protein. Neurology. 42 (1992) 149-156
5. Billette de Villemeur T., Gelot A., Deslys J.P., Dormont D., Duyckaerts C., Jardin L., Denni J., and Robain O. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol. Appl. Neurobiol. 20 (1994) 111-117
6. Billette de Villemeur T., Fournier J.-G., Escaig-Haye F., Robain O., and Brown P. Electronmicroscopic detection of prion-protein-fibers in brain from iatrogenic Creutzfeldt-Jakob disease. Lancet 345 (1995) 861-862
7. Borchelt D.R., Taraboulos A., and Prusiner S.B. Evidence for synthesis of scrapie prion protein in the endocytic pathway. J. Biol. Chem. 267 (1992) 16188-16199
8. Borchelt D.R., Koliatsos V.E., Guarnieri M., Pardo C.A., Sisodia S.S., and Price D.L. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous system. J. Biol. Chem. 269 (1994) 14711-14714
9. Brown H.R., Goller N., Rudelli G., Wolfe G.C., Wisniewski H.M., and Robakis N.K. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropath. 80 (1990) 1-6
10. Brown P., Coker-Vann M., Pomeroy K., Franko M., Asher D., Gibbs C., and Gajdusek D.C. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N. Engl. J. Med. 314 (1986) 547-551
11. Brown P., Goldfarb L.G., and Gajdusek D.C. The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet. 337 (1991) 1019-1022
12. Brown P., Gibbs Jr. C.J., Rodgers-Johnson P., Asher D.M., Sulima M., Bacote A., Goldfarb L.G., and Gadjusek D.C. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35 (1994) 513-529
13. Büeler H., Fischer M., and Lang Y. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-658
14. Büeler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
15. Caughey B., Race R.E., and Chesebro B. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J. Gen. Virol. 69 (1988) 711-716
16. Caughey B., and Raymond G.J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease and phospholipase sensitive. J. Biol. Chem. 266 (1991) 18217-18223
17. Clinton J., Forsyth C., Royston M.C., and Roberts G.W. Synaptic degeneration is the primary neuropathological feature in prion disease: A reliminary study. Neuroreport. 4 (1993) 65-68
18. Cohen F.E., Pan K.M., Huang Z., Baldwin M., Fletterick R.J., and Prusiner S.B. Structural clues to prion replication. Science. 264 (1994) 530-531
19. Collinge J., Whittington M.A., Sidie K.C.L., Smith C.J., Palmer M.S., Clarke A.R., and Jefferys J.G.R. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
20. DeArmond S., Mobley W., DeMott D., Barry R., Beckstead J., and Prusiner S.B. Changes in the localization of brain prion proteins during scrapie infection. Neurology 87 (1987) 1271-1280
21. DeArmond S.J., and Prusiner S.B. Etiology and pathogenesis of prion diseases. Am. J. Pathol. 146 (1995) 785-811
22. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., and Haase H.T. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. USA 88 (1991) 375-379
23. Doi-Yi R., Kitamoto T., and Tateishi J. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta. Neuropathol. 82 (1991) 260-265
24. Fournier J.G., Escaig-Haye F., Billette de Villemeur T., and Robain O. Ultrastuctural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C.R. Acad. Sci. 318 (1995) 339-344
25. Gajdusek D.C. Genetic control of nucleation and polymerization of host precursors to infectious amyloids in the transmissable amyloidoses in brain. Br. Med. Bull. 49 (1993) 913-931
26. Hay B., Prusiner S.B., and Lingappa V.R. Evidence for a secretory form of the cellular prion protein. Biochemistry. 26 (1987) 8110-8115
27. Hayward P.A.R., Bell J.E., and Ironside J.W. Prion protein immunocytochemistry: Reliable protocols for investigation of Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 20 (1994) 375-383
28. Harris D.A., Lele P., and Snider W.D. Localization of the mRNA for a chicken prion protein by in situ hybridization. Proc. Natl. Acad. Sci. USA 90 (1993) 4209-4313
29. Jeffrey M., Goodsir C.M., Bruce M.E., Mc Bride P.A., Fowler N., and Scott J.R. Murine scrapie-infected neurons in vivo release excess prion protein into the extracellular space. Neurosci. Lett. 174 (1994) 39-42
30. Kitamoto T., Shin R.W., Doh-ura K., Tomokane N., Miyazono M., Muramoto T., and Tateishi J. Abnomal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140 (1992) 1285-1294
31. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., and Caughey B. Cell-free formation of protease-resistant prion protein. Nature 370 (1994) 471-474
32. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., Fischer P., Masters C.L., and Price D.L. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87 (1990) 1561-1565
33. Kretzchmar H.A., Prusiner S.B., Stowring L.W., and DeArmond S.J. Scrapie prion proteins are synthetized in neurons. Am. J. Pathol. 122 (1986) 1-5
34. Liautard J.P. Prions and molecular chaperones. Arch. Virol. 7 (1993) 227-243
35. Liberski P.P., Guiroy D.C., Williams E.S., Yanagihara R., Brown P., and Gajdusek D.C. The amyloid plaque. In: Liberski P.P. (Ed). Light and Electron Microscopic Neuropathology of Slow Virus Disorders (1993), CRC Press, Boca Raton
36. Masliah E., and Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol. 3 (1993) 77-85
37. Merz P.A., Somerville R.A., Wisniewski H.M., and Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol. 54 (1981) 61-74
38. Mobley W.C., Neve R.L., Prusiner S.B., and Mc Kinley M.P. Nerve growth factor increase mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA 85 (1988) 9811-9815
39. Moser M., Colello R.J., Pott U., and Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 14 (1995) 509-517
40. Oesch B., Westaway D., Walchli M., Mc Kinley M.P., Kent S.B., Aebersold R., Barry R., Tempst P., Teplow D.B., Hood L.E., and Prusiner S.B. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40 (1985) 735-746
41. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., and Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90 (1993) 10962-10966
42. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
43. Prusiner S.B., Mc Kinley M.P., Bowman K.A., Bolton D.C., Bendheim P.E., Groth D.F., and Glenner G.G. Scrapie prions aggregate to form amyloid-like birefringents rods. Cell. 35 (1983) 349-358
44. Prusiner S.B. Molecular biology of prion diseases. Science 252 (1991) 1515-1522
45. Robakis N.K., Sawh P.R., Wolfe G.C., Rubenstein R., Carp R.I., and Innis M.A. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc. Natl. Acad. Sci. USA 83 (1986) 6377-6381
46. Safar J., Ceroni M., Gajdusek D.C., and Gibbs C.J. Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie-or Creutzfeldt-Jakob disease-infected brains. J. Infec. Dis. 163 (1991) 488-494
47. Safar J., Roller P.P., Gajdusek D.C., and Gibbs Jr. C.J. Conformational transitions, dissociation and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268 (1993) 20276-20284
48. Sarkozi E., Askanas V., and King Engel W. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Am. J. Pathol. 145 (1994) 1280-1284
49. Schubert W., Prior R., Weidemann A., Dircksen H., Multhaup G., Masters C.L., and Beyreuther K. Localization of Alzheimer beta-A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res. 563 (1991) 184-194
50. Sharp A., Loev S., Schilling G., Li S., Li X., Bao J., Wagster M., Kotzuk J., Steiner J., Lo A., Hedreen J., Sisodia S., Snyder S., Dawson T., Ryugo D., and Ross C. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14 (1995) 1065-1074
51. Tagliavini F., Prelli F., Porro M., Salmona M., Bugiani O., and Frangione B. A soluble form of prion protein in human cerebrospinal fluid: Implications for prion-related encephalopathies. Biochem. Biophys. Res. Commun. 184 (1992) 1398-1404
52. Taraboulos A., Jendroska K., Serban D., Yang S.L., DeArmond S.J., and Prusiner S.B. Regional mapping of prion proteins in brains. Proc. Natl. Acad. Sci. USA 89 (1992) 7620-7624
53. Tateishi J., Nagara J.H., Hikita K., and Sato Y. Amyloid plaques in the brain of mice with Creutzfeldt-Jakob disease. Ann. Neurol. 15 (1984) 278-280
54. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., and Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83 (1995) 79-90
55. Weissmann C. A unified theory of prion propagation. Nature 352 (1991) 679-683
56. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.L., Torchia M., Carlson G.A., and Prusiner S.B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76 (1994) 117-129
57. Wiley C.A., Burrola P.G., Buchmeier M.J., Wooddell M.K., Barry R.A., Prusiner S.B., and Lampert P.W. Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab. Invest. 57 (1987) 646-656